Health


 How Is HealthEquity (NASDAQ:HQY) Expanding Its Role in Financial Technology

How Is HealthEquity (NASDAQ:HQY) Expanding Its Role in Financial Technology

February 27, 2025 09:24 AM PST| By Team Kalkine Media

Highlights,HealthEquity has received multiple target price adjustments from major financial firms.,Institutional investors maintain significant holdings in the company.,Recent stockholder transactions reflect internal activity.,Market Position and In...

 How Is Bristol-Myers Squibb (NYSE:BMY) Expanding Its Market Influence

How Is Bristol-Myers Squibb (NYSE:BMY) Expanding Its Market Influence

February 27, 2025 08:22 AM PST| By Team Kalkine Media

Highlights,Bristol-Myers Squibb has seen adjustments in institutional holdings, reflecting shifts in market engagement.,Recent earnings reports showed revenue growth, with financial performance exceeding projections.,The company continues to expand i...

 How Warby Parker (NYSE:WRBY) Is Adapting to Market Trends

How Warby Parker (NYSE:WRBY) Is Adapting to Market Trends

February 27, 2025 08:15 AM PST| By Team Kalkine Media

Highlights,Warby Parker  recently received an upgrade from Roth Capital, signaling renewed interest in the company’s stock.,Institutional investors have shown increased engagement, with several firms adjusting their stakes.,The company continues to e...

 How Is Veeva Systems Inc. (NYSE:VEEV) Expanding Its Cloud-Based Solutions

How Is Veeva Systems Inc. (NYSE:VEEV) Expanding Its Cloud-Based Solutions

February 27, 2025 08:05 AM PST| By Team Kalkine Media

Highlights,Venturi Wealth Management LLC increased its stake in Veeva Systems by 2,716.7% in the fourth quarter, reflecting strong institutional engagement.,Veeva Systems opened at $221.53, experiencing a 2.0% decline amid a trading range between $17...

 Is Revvity's Strategic Shift Redefining Its Trajectory?

Is Revvity's Strategic Shift Redefining Its Trajectory?

February 27, 2025 02:36 AM PST| By Team Kalkine Media

Highlights,Major institutional investor reduced its stake in Revvity.,Company authorized a substantial stock repurchase program.,Robust financial metrics and a notable market capitalization observed.,Revvity, Inc. (NYSE:RVTY) operates within the heal...

 Is Hologic Pioneering Change in Medical Technology?

Is Hologic Pioneering Change in Medical Technology?

February 27, 2025 02:21 AM PST| By Team Kalkine Media

Highlights,Institutional investor adjustments have led to a shift in investment positions.,Executive share reallocation by top management has been observed.,The firm's stock performance remains steady within a defined trading range.,Hologic, Inc. (NA...

 Why is Humana (NYSE:HUM) Gaining Attention in the Healthcare Sector?

Why is Humana (NYSE:HUM) Gaining Attention in the Healthcare Sector?

February 27, 2025 02:09 AM PST| By Team Kalkine Media

Highlights,Humana Inc. is a key player in the healthcare sector, focusing on health insurance and managed care services.,The company has demonstrated consistent financial performance with a diverse product portfolio.,Strategic initiatives and partner...

 Why is Zoetis (NYSE:ZTS) Gaining Attention in the Animal Health Sector?

Why is Zoetis (NYSE:ZTS) Gaining Attention in the Animal Health Sector?

February 27, 2025 01:56 AM PST| By Team Kalkine Media

Highlights,Zoetis operates as a leading global animal health company, specializing in medicines and vaccines for livestock and pets.,The company has shown steady growth driven by its diversified product portfolio and strategic acquisitions.,Zoetis ma...

 Belite Bio (NASDAQ: BLTE) Announces Positive Interim Results from Phase 3 DRAGON Trial of Tinlarebant

Belite Bio (NASDAQ: BLTE) Announces Positive Interim Results from Phase 3 DRAGON Trial of Tinlarebant

February 27, 2025 01:49 AM PST| By Team Kalkine Media

Highlights,Belite Bio progresses Phase 3 DRAGON trial with positive interim analysis of Tinlarebant.,Data Safety Monitoring Board recommends trial continuation, with no changes to the sample size.,Tinlarebant demonstrates safety and stability in visu...

 Allworth Financial LP Increases Stake in Medical Properties Trust, Inc. (NYSE: MPW)

Allworth Financial LP Increases Stake in Medical Properties Trust, Inc. (NYSE: MPW)

February 27, 2025 12:29 AM PST| By Team Kalkine Media

Highlights,Institutional investors significantly increased their stake in Medical Properties Trust during the fourth quarter.,Analysts provide mixed ratings on Medical Properties Trust, with a predominant "Hold" consensus.,Medical Properties Trust co...

 Principal Financial Group Inc. holds a stock position valued at $14.84 million in Immunocore Holdings plc (NASDAQ:IMCR).

Principal Financial Group Inc. holds a stock position valued at $14.84 million in Immunocore Holdings plc (NASDAQ:IMCR).

February 27, 2025 12:29 AM PST| By Team Kalkine Media

Highlight,Principal Financial Group Inc. has reduced its stake in Immunocore Holdings by selling 43,461 shares, bringing its total ownership to 502,857 shares valued at $14.835 million.,Institutional interest continues to evolve with multiple acquisi...

 Principal Financial Group Inc. Increases Its Investment in Vericel Co. (NASDAQ:VCEL)

Principal Financial Group Inc. Increases Its Investment in Vericel Co. (NASDAQ:VCEL)

February 27, 2025 12:29 AM PST| By Team Kalkine Media

Highlight,Principal Financial Group Inc. raised its stake in Vericel Co. by 4.4% during the fourth quarter.,Vericel Co.'s stock saw multiple institutional investments and changes in positions.,Market analysts generally project a positive outlook with...

 Institutional Investors Show Renewed Interest in AbCellera Biologics (NASDAQ:ABCL)

Institutional Investors Show Renewed Interest in AbCellera Biologics (NASDAQ:ABCL)

February 27, 2025 12:29 AM PST| By Team Kalkine Media

Highlights,Growing Institutional Activity,: Increased investments from major institutions, including the State of New Jersey Common Pension Fund D, signal strong confidence in the company.,Stock Performance Gains,: A recent 3.5% rise in stock price r...

 Is Novo Nordisk A/S Pioneering Change in Global Healthcare?

Is Novo Nordisk A/S Pioneering Change in Global Healthcare?

February 26, 2025 11:23 PM PST| By Team Kalkine Media

Highlights,Global pharmaceutical leader focused on diabetes, obesity, and rare diseases.,Evaluation by rating firms falls within a moderate range.,Institutional trading activity and dividend adjustments reflect strong financial discipline.,Novo Nordi...

 Is Jamieson Wellness Reshaping the Health Products Sector?

Is Jamieson Wellness Reshaping the Health Products Sector?

February 27, 2025 02:22 AM EST| By Team Kalkine Media

Highlights,● Valuation adjustments by leading financial institutions have updated the stock’s financial outlook.,● Jamieson Wellness (TSX:JWEL) operates on a global scale in the health products industry.,● Robust liquidity ratios and market capitaliz...

 Could Viracta Therapeutics Drive a New Wave in Virus-Associated Cancer Care?

Could Viracta Therapeutics Drive a New Wave in Virus-Associated Cancer Care?

February 26, 2025 10:28 PM PST| By Team Kalkine Media

Highlights,Viracta Therapeutics (NASDAQ:VIRX) operates in the precision oncology field.,The company is set to release quarterly financial updates on Thursday, March 6th.,Nana-val, an all-oral combination therapy, is progressing through clinical devel...

 Is Xponential Fitness Embracing New Opportunities in the Boutique Fitness Sector?

Is Xponential Fitness Embracing New Opportunities in the Boutique Fitness Sector?

February 26, 2025 10:28 PM PST| By Team Kalkine Media

Highlights,Quarterly results are expected before the market opens on Thursday, March 6th,The company projects earnings per share of 0.39 and revenue of 81.12 million,The boutique fitness franchisor operates a diversified portfolio of recognizable bra...

 Could This Biosimulation Provider Redefine Healthcare?

Could This Biosimulation Provider Redefine Healthcare?

February 26, 2025 10:28 PM PST| By Team Kalkine Media

Highlights,Certara (NASDAQ:CERT) is scheduled to release its next earnings figures after the market closes on Thursday, March 6th, with the figure for the period stated at 0.12 per share.,The company’s stock has moved within a 52-week range from 9.41...

 Could This Biopharmaceutical Developer Advance Cancer Treatment?

Could This Biopharmaceutical Developer Advance Cancer Treatment?

February 26, 2025 10:28 PM PST| By Team Kalkine Media

Highlights,Revenue goals for the upcoming announcement stand at 34.17 million.,Stock recently opened at 2.49 within a 52-week range from 2.34 to 21.88.,Scheduled earnings release is on March 6th.,MacroGenics, Inc. (NASDAQ:MGNX) operates within the bi...

 Could Cartesian Therapeutics Transform Biotech Advancements?

Could Cartesian Therapeutics Transform Biotech Advancements?

February 26, 2025 10:28 PM PST| By Team Kalkine Media

Highlights,Quarterly results expected at negative eighty cents per share, revenue near one-tenth of one million dollars,Shares opened around eighteen dollars, reflecting a market capitalization near four hundred fifty-eight million dollars,Lead pipel...

Recent Articles






Investing Tips

Previous Next